We have recently identified a promoter proximal retinoic acid (RA)-responsive site in the 5' region of the HOXB1 gene. In this report, we have identified the second
fails to respond to RA, the endogenous HOXB1 gene can still be activated in NT2/D1 cells (1, 2) . The retention of inducibility of the intact gene strongly suggests the existence of a second pathway for RA responsiveness that is not mediated by the promoter.
In addition to in vitro inducibility by RA, the endogenous HOXB1 gene shows two phases of expression in the developing embryo (3) . In the primitive streak stage, the expression is restricted to the posterior half of the embryo, including the mesoderm and ectoderm. By early somite stage, HOXB1 expression becomes divided into two domains: the posterior half of the embryo and the prospective rhombomere 4 . Our preliminary analysis of transgenic mice harboring HOXB1 reporter genes identifies the RA-responsive site in the promoter as critical in establishing the expression within rhombomere 4. However, the early and late phases of HOXB1 expression have been reported to be sensitive to RA (4, 5) . These lines of evidence strongly support the existence of another signaling pathway controlling the early expression of HOXB1 gene in the posterior half of the embryo. The search for this pathway focused our attention on the 3' portion of the gene and resulted in the identification of an RA-responsive element (RARE) composed of a DR-2-type motif whose activity is dependent on a flanking tissue-specific enhancer.
MATERIALS AND METHODS
Plasmids. A DNA fragment containing the thymidine kinase (TK) luciferase gene was ligated into the Sal I site in pBluescript SK (+) vector (Stratagene) using the Sal I linker (pBS.TK.Luc). Various genomic DNA fragments derived from 3' regions of HOXB1 gene were inserted into the polylinker site of pBS.TK. Cell Cultures and Transfection. Embryonal carcinoma cell lines P19 and NT2/D1 (6) and monkey kidney cell line CV-1 were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Irvine Scientific).
Transfection was performed by using calcium phosphate precipitation method as described (7) . For the cotransfection assay, 0.1 ,ug of pCMX-hRARa and/or 0.1 ,ug of pCMXhRXRa were used. The total amount of pCMX expression plasmids was kept constant by using parental pCMX plasmid.
RESULTS
Our analysis indicates that virtually the entire HOXB cluster, which is >100 kb long, is essentially free of repetitive DNA (unpublished). This unique sequence DNA continues 7 kb downstream of the 3' end of the HOXBI gene, after which numerous repetitive sequence elements are found ( Fig. 1A ; data not shown). Constructs targeting the 7-kb region used in this analysis are shown in Fig. 1A . Note that the genomic DNA fragments derived from the 3' region of this gene are ligated to a TK.Luc reporter in a fashion that preserves the natural downstream genomic configuration. When making these reporter constructs, we chose the promoter of the herpes simplex virus TK gene (TK promoter) to establish the independence of this regulation from the HOX promoter. As shown in Fig. 1A tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Results obtained by using these constructs indicate that the RA inducibility was encoded by the overlapping fragments in constructs 4 and 5, with marginal or no inducibility in fragments 6 and 7 (Fig. 1A) . These results lead us to focus on the 0.2-kb BamHI-Sma I fragment. Deletion analysis of the 0.2-kb BamHI-Sma I fragment localized RA responsiveness to a 5' 110-nt subfragment (data not shown). The sequence of this region is shown in Fig. 1B and includes a direct repeat of 5'-AGGT(A/C)A-3' (in antisense orientation) spaced by 2 nt (DR-2B) (Fig. 1B) . We were unable to find any other RARE motif from our sequence analysis of 1.6 kb spanning this region. To further analyze RA responsiveness, an oligonucleotide containing this DR-2 sequence (underlined sequence in Fig. 1B ) was ligated into the 3' end of the TK.Luc transcription unit as single and triple copies [TK.Luc(DR-2B), and TK.Luc(DR-2B)3, respectively]. These constructs were transfected into P19 and NT2/D1 cells and examined for hormonal response. Following addition of 1 ,uM RA, the construct harboring three DR-2B motifs (Fig. 1C, lane  4) displayed robust inducibility (24-fold) in P19 cells, yet (for reasons described below) only a weak response was evident in NT2/D1 cells. A single DR-2 showed only weak activity in either cell (Fig. 1C, lane 3) . The TKf3RE. The ability of RAR and RXR to form either homo-or heterodimers on the HOXB DR-2A and DR-2B was confirmed by using a gel retardation assay, as demonstrated in the preceding paper (7) . To explore the in vivo roles ofthe receptor heterodimer on HOX gene regulation, the TK.Luc.(DR-2B)2 reporters were transfected with RARa and/or RXRa expression vectors into NT2/D1 cells. As shown in Fig. 1D , dramatic synergism of RARa and RXRa was observed. Without cotransfection of the receptor vectors, TKLuc.(DR-2B)2 was induced 7-fold by RA. Individually, RARa or RXRa expression enhanced the activity (31-fold and 11-fold, respectively), whereas cotransfection of both expression plasmids exerted the remarkable synergism on this construct (74-fold induction). From the activation and the DNA binding assays, we conclude that the DR-2B serves as a bona fide and effective target for the RARRXR heterodimer.
As originally observed in Fig. 1 A and C, a restriction fragment including sequences flanking the DR-2B motif served as a better response element than the synthetic DR-2 motif alone. We considered the possibility that an additional site in constructs 4 and 5 might act cooperatively to enhance the function of the DR-2. To test this hypothesis three new constructs were generated (Fig. 2) . These include the TK reporter with various combinations of the DR-2B motif (shown as blocks) and a downstream 90-bp sequence (shown as a double line). These plasmids were transfected to NT2/D1 cells and monitored for RA responsiveness in the presence of cotransfected RAR and RXR expression plasmids. As shown in Fig. 2 These results suggest that the HOXB RARE activity may be augmented by an adjacent potentiating sequence. Interestingly, the 90-bp sequence failed to augment RA responsiveness in CV-1 cells with RAR and/or RXR expression vectors (Fig.  2) . From gel retardation assays using the 90-bp region as probe, we have been able to identify a protein referred to as retinoid-activating protein (RAP) from NT2/D1 and P19 cell nuclear extracts (but not in CV-1 cell extracts) that specifically binds to this region (data not shown). This supports the transfection data and suggests that, in a fashion similar to the 5' RARE, the unique combination of regulatory sequences may give rise to a cell type-specific RARE. Several reports have recently demonstrated that RAR and RXR have a high degree of cooperativity in binding target DNA and that heterodimer formation on a DR-S motif strongly stimulates transcriptional activation (9) (10) (11) (12) . As shown in our preceding paper (7), the cooperative RAR-RXR binding was also observed on the DR-2A and DR-2B targets. Competition studies indicate these may be lower affinity than the heterodimer bound to a DR-5, which may explain the lower activation of a single DR-2 (2-fold) compared with RARI32 RARE (10-fold) in P19 cells. However, three copies of either HOXB DR-2 produced a robust activation of the TK promoter. In NT2/D1 cells, cotransfection of RAR and RXR expression vectors dramatically increased RA inducibility through the DR-2. The HOXB DR-2B sequence closely resembles the RARE (5'-AGGTCAAAAGGTCA-3') found in the promoter of mouse cellular retinol binding protein (13) and is distinct from the DR-S response element identified in the 3' region of Hox-Al gene (14) . Our analysis indicates that though the DR-2s are effective binding sites they are ineffective response elements. Accordingly, they are ideally suited for cooperative interaction with other regulatory proteins.
DISCUSSION
Because many HOX genes are retinoid inducible, a major question to be resolved is whether this is a result of direct or indirect effects of these hormones. The work reported here identifies a DR-2-type RARE in the 3' extragenic region of the HOXB1 gene that serves as a direct binding site for the RXR-RAR heterodimer. This is distinct from the previously identified 5' RARE in the promoter. Each of these enhancers is dependent on an adjacent coactivator that appears to confer the cell specificity and possibly the developmental specificity to the response elements. A model for this pathway of regulation is shown in Fig. 3 RARE is required for the establishment of early HOXB1 gene expression in the primitive streak stage embryo and that the 5' RARE involves the establishment of rhombomere 4-specific expression (unpublished data).
It is important to note that Hoxa-1 is also a paralogue of the Drosophila labial gene and is reported to have a DR-5-type RARE in its downstream 3' region (14) . The Hoxa-1 gene is expressed in the early primitive streak stage, where the teratogenic doses of RA induce the expansion of its expression domain in a fashion similar to that observed for the HOXB1 gene (3) . These lines of evidence strongly suggest that the 3' RARE is responsible for the establishment of the early phase of expression of labial paralogues and could be a common property shared by other HOX gene clusters. In contrast to the Hoxa-1 gene, the HOXB1 gene shows the unique and characteristic expression in the developing rhombomere 4 (3). Teratogenic doses of RA also expand the domain of this latephase expression (3, 4) , suggesting that RA could be involved in this process through the unique 5' RARE in the promoter.
Together, these studies have identified two tissue-specific coactivators that enable the HOXB1 gene to respond to RA in different cell types in vitro and in vivo. Isolation of coactivator genes will provide further understanding of the mechanisms controlling HOX gene expression in the developing embryo.
